Citations

Clear

3314 citation(s) found for "Do, Alexander".

Laser Acupuncture: A Concise Review
Chon, Tony Y. , Mallory, Molly J., Yang, Juan , Bublitz, Sara E. , Do, Alexander , Dorsher, Peter T.

Mayo Clinic

Medical Acupuncture | June 5, 2019 | Volume: 31 | Issue: 3 | Pages: 164-168

10.1089/acu.2019.1343 | PMID 31297170 Get It

Eosinophils downregulate lung alloimmunity by decreasing TCR signal transduction
Onyema, Oscar Okwudiri , Guo, Yizhan , Mahgoub, Bayan , Wang, Qing , Manafi, Amir , Mei, Zhongcheng , Banerjee, Anirban , Li, Dongge , Stoler, Mark H. , Zaidi, Melissa T. , Schrum, Adam G. , Kreisel, Daniel , Jacobsen, Elizabeth A. , Krupnick, Alexander S. , Schrum, Adam G , Jacobsen, Elizabeth A , Gelman, Andrew E

Mayo Clinic

JCI Insight | June 5, 2019 | Volume: 4 | Issue: 11 | Pages: No page available

10.1172/jci.insight.128241 | PMID 31167966 Get It

Despite the accepted notion that granulocytes play a universally destructive role in organ and tissue grafts, it has been recently described that eosinophils can facilitate immunosuppression-mediated acceptance of murine lung allografts. The mechanism of eosinophil-mediated tolerance, or their role in regulating alloimmune responses in the absence of immunosuppression, remains unknown. Using lung transplants in a fully MHC-mismatched BALB/c (H2 d ) to C57BL/6 (H2 b ) strain combination, we demonstrate that eosinophils downregulate T cell–mediated immune responses and play a tolerogenic role even in the absence of immunosuppression. We further show that such downregulation depends on PD-L1/PD-1–mediated synapse formation between eosinophils and T cells. We also demonstrate that eosinophils suppress T lymphocyte responses through the inhibition of T cell receptor/CD3 (TCR/CD3) subunit association and signal transduction in an inducible NOS–dependent manner. Increasing local eosinophil concentration, through administration of intratracheal eotaxin and IL-5, can ameliorate alloimmune responses in the lung allograft. Thus, our data indicate that eosinophil mobilization may be utilized as a novel means of lung allograft–specific immunosuppression.
Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: are they safe
Yang, Hayang , Veldtman, Gruschen , Bouma, Berto J. , Budts, Werner , Niwa, Koichiro , Meijboom, Folkert J., Egbe, Alexander C. , Schwerzmann, Markus , Broberg, Craig S. , Buber, Jonathan , Tsai, Shane, Post, Martijn C. , Mulder, Barbara J.M. , Egbe, Alexander Chima, Schwerzmann, Markus , Scognamiglio, Giancarlo , Morissens, Marielle , Polyzois, Ioannis , Greutmann, Matthias , Dijk, Arie P.J. van , Aboulhosn, Jamil , Bouma, Berto J

Mayo Clinic

Open Heart | June 4, 2019 | Volume: 6 | Issue: 1 | Pages: e000985

10.1136/openhrt-2018-000985 | PMID 31245011 Get It

Background In Fontan patients with atrial arrhythmias (AA), non-vitamin K antagonist oral anticoagulants(NOACs) have a class III recommendation according to the Pediatric & Congenital Electrophysiology Society (PACES)/Heart Rhythm Society (HRS) guideline in 2014, due to lack of data on outcomes as opposed to evidence of harm. To address this gap in data, we investigated the safety and efficacy of NOACs in adults with a Fontan circulation in a worldwide study. Methods This is an international multicentre prospective cohort study, using data from the NOTE ( n on-vitamin K antagonist o ral anticoagulants for t hrombo e mbolic prevention in patients with congenital heart disease) registry. The study population comprised consecutive adults with a Fontan circulation using NOACs. Follow-up took place at 6 months and yearly thereafter. The primary endpoints were thromboembolism and major bleeding. Secondary endpoint was minor bleeding. Results From April 2014 onward, 74 patients (mean age 32±10 years (range 18–68), 54% male) with a Fontan circulation using NOACs were included. During a median follow-up of 1.2 (IQR 0.8–2.0) years, three thromboembolic events (2.9 per 100 patient-years (95% CI 0.7 to 7.6)) and three major bleedings (2.9 per 100 patient-years (95% CI 0.7 to 7.6)) occurred in five atriopulmonary Fontan and one total cavopulmonary connection Fontan patients with AA. Fifteen patients experienced minor bleeding episodes (15.8 per 100 patient-years (95% CI 9.1 to 25.2)). In patients (n=37) using vitamin K antagonists (VKAs) prior to the initiation of NOAC, annual incidence of historical thromboembolic events and major bleeding were 2.4% (95% CI 0.4% to 7.4%) (n = 2) and 1.2% (95% CI 0.7% to 5.1%) (n = 1), respectively. Conclusions In this review of the largest Fontan cohort using NOACs with prospective follow-up, NOACs appear to be well tolerated and their efficacy and safety during short-term follow-up seem comparable to VKAs. Longer term data are required to confirm these promising short-term results.
Human Umbilical Venous Endothelial Cells: Early Predictors of Cardiovascular Risk in Offspring?
LaMarca, Babbette , Reckelhoff, Jane F. , Garovic, Vesna D. , Alexander, Barbara T.

Mayo Clinic

Hypertension | June 3, 2019 | Volume: 74 | Issue: 1 | Pages: 32-34

10.1161/hypertensionaha.119.12652 | PMID 31154902 Get It

Total knee arthroplasty after distal femoral osteotomy long-term survivorship and clinical outcomes
Limberg, Afton K. , Athey, Alexander G., Perry, Kevin I. , Pagnano, Mark W. , Chalmers, Brian P. , Abdel, Matthew P.

Mayo Clinic

The Bone & Joint Journal | June 1, 2019 | Volume: 101-B | Issue: 6 | Pages: 660-666

10.1302/0301-620x.101b6.bjj-2018-1334.r2 | PMID 31154844 Get It

AimsThere is little literature about total knee arthroplasty (TKA) after distal femoral osteotomy (DFO). Consequently, the purpose of this study was to analyze the outcomes of TKA after DFO, with particular emphasis on: survivorship free from aseptic loosening, revision, or any re-operation; complications; radiological results; and clinical outcome.Patients and MethodsWe retrospectively reviewed 29 patients (17 women, 12 men) from our total joint registry who had undergone 31 cemented TKAs after a DFO between 2000 and 2012. Their mean age at TKA was 51 years (22 to 76) and their mean body mass index 32 kg/m2(20 to 45). The mean time between DFO and TKA was ten years (2 to 20). The mean follow-up from TKA was ten years (2 to 16). The prostheses were posterior-stabilized in 77%, varus-valgus constraint (VVC) in 13%, and cruciate-retaining in 10%. While no patient had metaphyseal fixation (e.g. cones or sleeves), 16% needed a femoral stem.ResultsThe ten-year survivorship was 95% with aseptic loosening as the endpoint, 88% with revision for any reason as the endpoint, and 81% with re-operation for any reason as the endpoint. Three TKAs were revised for instability (n = 2) and aseptic tibial loosening (n = 1). No femoral component was revised for aseptic loosening. Patients under the age of 50 years were at greater risk of revision for any reason (hazard ratio 7; p = 0.03). There were two additional re-operations (6%) and four complications (13%), including three manipulations under anaesthetic (MUA; 10%). The Knee Society scores improved from a mean of 50 preoperatively (32 to 68) to a mean of 93 postoperatively (76 to 100; p < 0.001).ConclusionA cemented posterior-stabilized TKA has an 88% ten-year survivorship with revision for any reason as the endpoint. No femoral component was revised for aseptic loosening. Patients under the age of 50 years have a greater risk of revision. The clinical outcome was significantly improved but balancing the knee was challenging in 13% of TKAs requiring VVC. Overall, 10% of TKAs needed an MUA, and 6% of TKAs were revised for instability. Cite this article: Bone Joint J 2019;101-B:660–666.
Elevated ventricular filling pressures and long‐term survival in adults post‐Fontan
Miranda, William R. , Hagler, Donald J. , Taggart, Nathaniel W. , Borlaug, Barry A. , Connolly, Heidi M. , Egbe, Alexander C. , Taggart, Nathaniel W , Borlaug, Barry A

Mayo Clinic

Catheterization and Cardiovascular Interventions | May 30, 2019 | Volume: 95 | Issue: 4 | Pages: 803-809

10.1002/ccd.28340 | PMID 31145542 Get It

AbstractObjectiveTo assess the association between elevated ventricular‐end diastolic pressures (VEDP) and pulmonary artery wedge pressure (PAWP) on long‐term survival in adult Fontan patients.BackgroundThe impact of ventricular filling pressures on long‐term survival in adults post‐Fontan palliation is unknown.MethodsWe included 148 adult Fontan patients (age ≥ 18 years) without atrioventricular valve prosthesis or pulmonary vein stenosis undergoing arterial and venous catheterization between December 1999 and November 2017. VEDP was defined as ≥12 mmHg and PAWP as >12 mmHg based on optimal cut‐offs for prediction of mortality on receiver‐operator curves (AUC 0.63 and 0.66, respectively).ResultsMean age was 31.3 ± 9.2 years and 48.6% of patients were females. Most common congenital defects were tricuspid atresia (36.4%) and double‐inlet left ventricle (28.3%); 59.5% patients had atriopulmonary Fontan connections. Mean VEDP was 11.5 ± 4.7 mmHg and PAWP 10.6 ± 4.5 mmHg (correlation coefficient .76). During a follow‐up of 6.0 ± 4.8 years (median 5.4, IQR 1.4–9.4), there were 45 deaths (30.4%). Overall survival was lower in patients with VEDP ≥ 12 compared to those with VEDP < 12 mmHg (p = .02). Similarly, survival was lower in patients with PAWP>12 compared to patients with PAWP ≤ 12 mmHg (p < .0001). In the multivariate model, PAWP was an independent predictor of death (HR 1.1 per mmHg, 95% CI 1.02–1.15, p = .009) whereas VEDP was not (HR 1.1 per mmHg, 95% CI 1.0–1.13; p = .08).ConclusionPAWP but not VEDP was independently associated with long‐term overall mortality in adult Fontan patients. Perhaps PAWP rather than VEDP should be used in the risk stratification of these patients.
Effect of the location of the split of the subscapularis on range of motion and stability of the glenohumeral joint following Latarjet or Trillat procedures
Nourissat, Geoffroy , Hooke, Alex, Berglund, Lars , Thoreson, Andrew R. , An, K-N, Werthel, J-D., Hooke, Alexander W. , An, K-N.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | May 30, 2019 | Volume: 7 | Issue: 5_suppl3 | Pages: No page available

10.1177/2325967119s00202 Get It

Aim: Compare the effect of Latarjet and Trillat procedures on glenohumeral stability and range of motion. Background: Little is known about the impact of the location of the sling effect on joint stability and range of motion. Methods: 12 cadaveric shoulders were cleaned of soft tissue except for the subscapularis, conjoined tendon, and anterior capsule. A custom-made apparatus generating anterior humeral translation and joint compression was used. The machine applied compression load in the medial direction. The subscapularis and conjoint tendon were loaded. Internal/external range of motion and joint stability were assessed at 0°, 30° and 60° glenohumeral abduction. Range of motion was assessed by rotating the humeral shaft. Joint stability was assessed at maximum external rotation, translating the humerus. Specimen were tested in five conditions: 1) intact shoulder, 2) 6-mm bony glenoid defect (20% defect) 3) Trillat procedure, 4) Latarjet procedure with subscapularis split at the junction between its superior 2/3rds and inferior 1/3 rd, 5) Latarjet procedure with subscapularis split at the superior 1/3rds and inferior 2/3rds. Means were compared with a full factorial-repeated measures ANOVA with pairwise post hoc comparisons. Results: Peak translation force and stability ratio were significantly lower with the glenoid defect when compared to the intact and all the repaired conditions at all levels of glenohumeral abduction. The level of the subscapularis split had no significant influence on these values and no significant difference could be found between Trillat and Latarjet procedures. Range of motion in internal and external rotation were not significantly different between the different conditions. Conclusions: Joint stability and range of motion after a Latarjet are not impacted by the location of the subscapularis muscle split. Trillat and Latarjet techniques provide comparable stabilization of the joint, even in the presence of a critical bony defect of the glenoid.
BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection
Zhu, Bibo , Zhang, Ruixuan, Li, Chaofan , Jiang, Li , Xiang, Min , Ye, Zhenqing , Kita, Hirohito , Melnick, Ari , Sun, Jie , Sun, Jie , Kita, H , Melnick, Ari , Li, Chaofan , Dent, Alexander L.

Mayo Clinic

Proceedings of the National Academy of Sciences | May 28, 2019 | Volume: 116 | Issue: 24 | Pages: 11888-11893

10.1073/pnas.1902310116 | PMID 31138703 Get It

Neutrophils are vital for antimicrobial defense; however, their role during viral infection is less clear. Furthermore, the molecular regulation of neutrophil fate and function at the viral infected sites is largely elusive. Here we report that BCL6 deficiency in myeloid cells exhibited drastically enhanced host resistance to severe influenza A virus (IAV) infection. In contrast to the notion that BCL6 functions to suppress innate inflammation, we find that myeloid BCL6 deficiency diminished lung inflammation without affecting viral loads. Using a series of Cre-transgenic, reporter, and knockout mouse lines, we demonstrate that BCL6 deficiency in neutrophils, but not in monocytes or lung macrophages, attenuated host inflammation and morbidity following IAV infection. Mechanistically, BCL6 bound to the neutrophil gene loci involved in cellular apoptosis in cells specifically at the site of infection. As such, BCL6 disruption resulted in increased expression of apoptotic genes in neutrophils in the respiratory tract, but not in the circulation or bone marrow. Consequently, BCL6 deficiency promoted tissue neutrophil apoptosis. Partial neutrophil depletion led to diminished pulmonary inflammation and decreased host morbidity. Our results reveal a previously unappreciated role of BCL6 in modulating neutrophil apoptosis at the site of infection for the regulation of host disease development following viral infection. Furthermore, our studies indicate that tissue-specific regulation of neutrophil survival modulates host inflammation and tissue immunopathology during acute respiratory viral infection.